However, there was no difference between subgroups in terms of gender, body mass index (BMI), biochemical parameters, alpha-fetoprotein level, the presence of cirrhosis, and the severity of tumor categorized by the Barcelona Clinic Liver Cancer (BCLC) staging system (Forner et al. 2018). This evidence concerns the gene AFP and Cirrhosis.